Rating: Buy

Executive Summary: Establish/grow a 3-5% core NVDA position starting with a first tranche (~2%) at current levels (~$215), never exceeding 5% until the $232 upper Bollinger resistance clears on volume. Keep the hard stop at $195 (below the 200-day SMA) to cap worst-case portfolio loss near 0.19-0.25% per tranche. Scale the remaining tranches on either a confirmed breakout above $232 on above-average volume OR a pullback toward the $208-$212 confluence (10-EMA/Bollinger middle/50-SMA). Reduce exposure on any weekly close below $195. Time horizon: 3-6 months through the next earnings catalyst.

Investment Thesis: The Aggressive Analyst decisively wins the fundamental debate: NVDA's 85% YoY revenue growth, 71% net margins, $96.7B annual FCF, PEG of 0.62, and forward P/E of ~17.6x against a $5.45T market cap represent a structural AI supercycle, not a cyclical peak. The SpaceX exclusivity win—secured despite AMD's $566M financial overture—is direct evidence that the CUDA moat is widening, confirmed by hyperscaler-locked capex, the OpenAI/SB Energy $100B credit support, and the $500B financing partnership. The fortress balance sheet ($80.6B cash vs $12.35B debt, 3.44 current ratio, $107B working capital) makes NVDA the creditor rather than the debtor in the AI financing complex, giving it relative resilience to a sector credit scare.

The bear's concerns are legitimate but not disqualifying. The $15.9B non-operating investment gains do inflate one quarter's earnings, lifting sustainable trailing multiple toward ~24x (still reasonable). The $70B off-balance-sheet credit backstops are a real systemic tail risk, but NVDA can absorb a full partnership loss and still remain net cash positive. The 2.2 beta and macro headwinds (hawkish Fed, oil spike, negative jobs) argue for disciplined sizing, not abandonment—a 30% correction on a capped 5% position costs only 1.5% of the portfolio. Prior lessons strongly validate this constructive call: the 2026-08-01 Buy (+6.3% alpha) proved the cost of waiting for a perfect pullback exceeds the benefit; the 2026-08-08 Overweight (+3.1% alpha) confirmed that fundamental momentum outperforms near-term technical stretch. The disciplined tranche structure respects both the Conservative Analyst's timing caution and the Neutral Analyst's confirmation framework while capturing the Aggressive Analyst's proven directional conviction.

Price Target: 260.0

Time Horizon: 3-6 months